Results 61 to 70 of about 192,096 (187)
Evaluating the Specificity of Antisense Oligonucleotide Conjugates: A DNA ARRAY ANALYSIS [PDF]
Antisense oligonucleotides are potentially powerful tools for selective control of cellular and viral gene expression. Crucial to successful application of this approach is the specificity of the oligonucleotide for the chosen RNA target.
Fisher, Michael H. +5 more
core +1 more source
High levels of plasma apolipoprotein B-100 (apoB-100), the principal apolipoprotein of LDL, are associated with cardiovascular disease. We hypothesized that suppression of apoB-100 mRNA by an antisense oligonucleotide (ASO) would reduce LDL cholesterol ...
Rosanne M. Crooke +5 more
doaj +1 more source
Spinocerebellar ataxia type 3 (SCA3) is a fatal, late-onset neurodegenerative disorder characterized by selective neuropathology in the brainstem, cerebellum, spinal cord, and substantia nigra.
Lauren R. Moore +9 more
doaj +1 more source
Meeting report: antisense oligonucleotides.
The use of antisense oligonucleotides as a therapeutic tool in modulating gene expression represents a newly established strategy for treating diseases. Such oligomers may be designed to complement a region of a specific gene or messenger RNA. Using this approach, oligonucleotides can serve as a potential block of transcription or translation through ...
G, Martinelli, S, Ferrari
openaire +3 more sources
Summary: SCN2A loss-of-function variants cause a range of neurodevelopmental disorders. Here, we present a protocol to induce severe Scn2a insufficiency in mice.
Melody Li, Bernd Kuhn
doaj +1 more source
Schematic of the tandem antisense oligonucleotide approach.
WT and Mut mRNA can interact with the gapmer or inhibitor, resulting in the formation of the most favorable thermodynamically duplexes (WT RNA/inhibitor and Mut RNA/gapmer).
Jolanta Lisowiec-Wachnicka (823327) +4 more
core +1 more source
Novel Targeted Therapy for Precursor B-Cell Acute Lymphoblastic Leukemia: Anti-CD22 Antibody-MXD3 Antisense Oligonucleotide ...
Cathy Chen (5816591) +13 more
core +1 more source
Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex
Antisense oligonucleotides, and particularly those with phosphorothioate backbones, have emerged as potential gene specific therapeutic agents and are currently undergoing evaluation in clinical trials for a variety of diseases.
Stein, Cy A. +11 more
core +1 more source
Antisense oligonucleotide development for the treatment of muscular dystrophies
Introduction: Depending upon the chemistry and annealing target, antisense oligonucleotides can be used to modify gene expression through several distinct modes of action.
Bao, T.L. +3 more
core
Design of antisense oligonucleotides
Satoshi, Obika, Yuuya, Kasahara
openaire +3 more sources

